”Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins”. International Journal of Pharmaceutics 179 (1): sid. 65–71. March 1999. doi:10.1016/S0378-5173(98)00382-2. PMID 10053203.
”Sublingual Administration of Testosterone-Hydroxypropyl-β-Cyclodextrin Inclusion Complex Simulates Episodic Androgen Release in Hypogonadal Men”. The Journal of Clinical Endocrinology and Metabolism 72 (5): sid. 1054–9. May 1991. doi:10.1210/jcem-72-5-1054. PMID 1902483.
”Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins”. International Journal of Pharmaceutics 179 (1): sid. 65–71. March 1999. doi:10.1016/S0378-5173(98)00382-2. PMID 10053203.
”Sublingual Administration of Testosterone-Hydroxypropyl-β-Cyclodextrin Inclusion Complex Simulates Episodic Androgen Release in Hypogonadal Men”. The Journal of Clinical Endocrinology and Metabolism 72 (5): sid. 1054–9. May 1991. doi:10.1210/jcem-72-5-1054. PMID 1902483.